全文获取类型
收费全文 | 114511篇 |
免费 | 11243篇 |
国内免费 | 74篇 |
专业分类
125828篇 |
出版年
2022年 | 785篇 |
2021年 | 1701篇 |
2020年 | 972篇 |
2019年 | 1245篇 |
2018年 | 1615篇 |
2017年 | 1420篇 |
2016年 | 2370篇 |
2015年 | 3928篇 |
2014年 | 4418篇 |
2013年 | 5455篇 |
2012年 | 7142篇 |
2011年 | 7133篇 |
2010年 | 4636篇 |
2009年 | 4192篇 |
2008年 | 6002篇 |
2007年 | 6051篇 |
2006年 | 5822篇 |
2005年 | 5621篇 |
2004年 | 5488篇 |
2003年 | 5281篇 |
2002年 | 5031篇 |
2001年 | 2711篇 |
2000年 | 2450篇 |
1999年 | 2392篇 |
1998年 | 1701篇 |
1997年 | 1290篇 |
1996年 | 1218篇 |
1995年 | 1069篇 |
1994年 | 1041篇 |
1993年 | 1083篇 |
1992年 | 1621篇 |
1991年 | 1603篇 |
1990年 | 1524篇 |
1989年 | 1423篇 |
1988年 | 1378篇 |
1987年 | 1241篇 |
1986年 | 1085篇 |
1985年 | 1145篇 |
1984年 | 1103篇 |
1983年 | 909篇 |
1982年 | 867篇 |
1981年 | 828篇 |
1980年 | 744篇 |
1979年 | 855篇 |
1978年 | 770篇 |
1977年 | 693篇 |
1976年 | 601篇 |
1975年 | 658篇 |
1974年 | 710篇 |
1973年 | 568篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Minh C. Nguyen Guang Huan Tu Kathryn E. Koprivnikar Melissa Gonzalez-Edick Karin U. Jooss Thomas C. Harding 《Cancer immunology, immunotherapy : CII》2010,59(9):1313-1323
A critical factor in clinical development of cancer immunotherapies is the identification of tumor-associated antigens that
may be related to immunotherapy potency. In this study, protein microarrays containing >8,000 human proteins were screened
with serum from prostate cancer patients (N = 13) before and after treatment with a granulocyte–macrophage colony-stimulating factor (GM-CSF)-secreting whole cell immunotherapy.
Thirty-three proteins were identified that displayed significantly elevated (P ≤ 0.05) signals in post-treatment samples, including three proteins that have previously been associated with prostate carcinogenesis,
galectin-8, T-cell alternative reading frame protein (TARP) and TNF-receptor-associated protein 1 (TRAP1). Expanded analysis
of antibody induction in metastatic, castration-resistant prostate cancer (mCRPC) patients (N = 92) from two phase 1/2 trials of prostate cancer immunotherapy, G-9803 and G-0010, indicated a significant (P = 0.03) association of TARP antibody induction and median survival time (MST). Antibody induction to TARP was also significantly
correlated (P = 0.036) with an increase in prostate-specific antigen doubling time (PSADT) in patients with a biochemical (PSA) recurrence
following prostatectomy or radiation therapy (N = 19) from in a previous phase 1/2 trial of prostate cancer immunotherapy, G-9802. RNA and protein encoding TARP and TRAP1
was up-regulated in prostate cancer tissue compared to matched normal controls. These preliminary findings suggest that antibody
induction to TARP may represent a possible biomarker for treatment response to GM-CSF secreting cellular immunotherapy in
prostate cancer patients and demonstrates the utility of using protein microarrays for the high-throughput screening of patient-derived
antibody responses. 相似文献
13.
14.
15.
16.
17.
18.
Abstract Electrofusion between cells of yeast strains with different genetic markers in isotonic sorbitol solutions leads to high yields of hybrids when 0.1 mM Ca2+ and 0.5 mM Mg2+ salts are aded. On average, 1000–2000 hybrids are obtained when electrofusion is performed (in a helical chamber) compared to a yield of about 40–120 in the absence of these bivalent cations. A further increase in yield can be achieved by the addition of 1 mg/ml albumin, which results in up to 4000 hybrids per experimental run. The entire fusion process leads to very reproducible results in the presence of these substances. 相似文献
19.
20.